Prognostic Stage IV Breast Cancer AJCC v8 Recruiting Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05092373Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxTreatment